T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Kilroy Realty
KRC
$4.3B
| $72.9M | 0.01% |
1,241,441
-121,483
| -9% | -$7.36M |
|
727
Nordson
NDSN
$17.3B
| $72.7M | 0.01% |
383,000
-36,056
| -9% | -$6.11M |
|
728
Heritage Financial
HFWA
$1.23B
| $72.3M | 0.01% |
3,614,367
-29,244
| -0.8% | -$551K |
|
729
Gentherm
THRM
$1.32B
| $72.2M | 0.01% |
1,856,496
-47,062
| -2% | -$1.78M |
|
|
SUM
730
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $71.6M | 0.01% |
4,528,459
+52,839
| +1% | +$758K |
|
731
Watsco Inc
WSO
$12.9B
| $71.5M | 0.01% |
402,639
+7,126
| +2% | +$1.18M |
|
732
Devon Energy
DVN
$48.8B
| $71.4M | 0.01% |
6,293,568
+3,611,928
| +135% | +$41.2M |
|
|
GWPH
733
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $71.3M | 0.01% |
580,696
+86,085
| +17% | +$9.77M |
|
734
General Mills
GIS
$20.8B
| $71M | 0.01% |
1,152,439
-90,511
| -7% | -$5.46M |
|
735
Nucor
NUE
$61.8B
| $70.9M | 0.01% |
1,713,058
-1,906,131
| -53% | -$77M |
|
736
Church & Dwight Co
CHD
$24B
| $70.9M | 0.01% |
916,780
+10,416
| +1% | +$758K |
|
737
TransDigm Group
TDG
$68.9B
| $70.7M | 0.01% |
160,017
-22,003
| -12% | -$8.33M |
|
738
ICICI Bank
IBN
$106B
| $70.6M | 0.01% |
7,596,532
-240,428
| -3% | -$2.14M |
|
739
Alcoa
AA
$13.1B
| $70.3M | 0.01% |
6,250,363
+675,989
| +12% | +$6.05M |
|
740
NovoCure
NVCR
$2.02B
| $70M | 0.01% |
1,181,267
-69,744
| -6% | -$4.59M |
|
741
Charles River Laboratories
CRL
$13.4B
| $69.3M | 0.01% |
397,682
-207,395
| -34% | -$33.1M |
|
742
Emergent Biosolutions
EBS
$230M
| $69.1M | 0.01% |
874,402
-9,168
| -1% | -$683K |
|
743
Schrodinger
SDGR
$1.38B
| $68.9M | 0.01% |
751,957
-3,128
| -0.4% | -$182K |
|
744
BJ's Restaurants
BJRI
$1.42B
| $68.6M | 0.01% |
+3,276,878
| New | +$64.9M |
|
745
Knowles
KN
$3.23B
| $68.6M | 0.01% |
4,492,680
+2,805
| +0.1% | +$41.8K |
|
|
ENV
746
DELISTED
ENVESTNET, INC.
ENV
| $68.3M | 0.01% |
928,078
+4,739
| +0.5% | +$310K |
|
747
Campbell Soup
CPB
$6.94B
| $68.2M | 0.01% |
1,375,145
-1,031,693
| -43% | -$51.2M |
|
748
Mueller Water Products
MWA
$3.98B
| $68.2M | 0.01% |
7,234,440
-547,431
| -7% | -$4.9M |
|
749
CTS Corp
CTS
$1.79B
| $68.2M | 0.01% |
3,401,150
+279,062
| +9% | +$5.98M |
|
750
Glacier Bancorp
GBCI
$6.48B
| $68M | 0.01% |
1,928,041
-13,949
| -0.7% | -$517K |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.